← Back to news

Markets

Jim Cramer on Planet Labs: “It’s Not a Stock You Should Chase Blindly at These Levels”

Y

Jim Cramer on Rocket Lab: “While the Stock’s Cheaper Than SpaceX, It’s Still Pretty Darn Expensive”

Y

Jim Cramer on SpaceX: “The Long-Term Upside Is Conceivably Unfathomable”

Y

Jim Cramer on Astera Labs: “This Stock Is Out of This World”

Y

Jim Cramer on Progressive Corporation: “That Group Is Under a Lot of Pressure”

Y

Jim Cramer Agrees That Accenture Is “Being Outcompeted By OpenAI and Anthropic”

Y

Jim Cramer Explains Why Kroger’s “Margins Will Be Shrinking”

Y

Jim Cramer on Adobe: “It Was a Disappointing Quarter”

Y

Jim Cramer Says SaaS Companies Like Zscaler “Have Fallen Viciously Out of Favor on Wall Street”

Y

Jim Cramer Highlights Dave & Buster’s Decline Over Time

Y

Jim Cramer Points to SLB for Critical Insights Into International Oil Production

Y

Jim Cramer on Eli Lilly: “I Want You to Stay in the Stock”

Y

Elemental Royalty shares rise after winning spots in Russell and S&P/TSX gold benchmarks

Y

Rivian has bad news for hundreds of its workers

Y

Exxon Set to Supply LNG to South Africa’s First Import Terminal

Y

Up 30% in 1 Month, Is Dutch Bros Stock Still a Strong Buy Before July?

Y

Venture Global (VG) And Atlantic-SEE Expand LNG Sales Agreement To 1.0 MTPA

Y

PG&E (PCG) Surpasses 1 Million Grid-Connected Solar Customers

Y

AECOM (ACM) Strengthens Private Sector Aviation Push With David Rottblatt Hire

Y

Cheniere Energy (LNG) Closed A Private Offering Of $1.75 Billion In Senior Unsecured Notes

Y

Vistra (VST) Selected As The Preferred Power Provider For A $10 Billion KKR-Backed AI Infrastructure Venture

Y

Here’s What Analysts Say About ONEOK (OKE)

Y

NRG Energy (NRG) Hits 52-Week Low As Analysts See Upside

Y

AES Corporation (AES) Prices $600M 2029 Notes And $400M 2033 Notes In $1 Billion Offering

Y

Grayscale Names 5 DeFi Altcoins With Real Utility

Y

The Stock Market Is Waiting on the Fed

Y

Veteran Pharma VC Insider Buys 25,000 Nuvation Bio Shares as New Drug Gains Momentum

Y

Allbirds Stock Pumps Again as Sneaker Firm Completes AI Pivot, Rebranding to Smartbird

Y

Figure Technology (FIGR) Establishes Funding Arrangement With Cross River Bank

Y

Optimism Surrounds Uranium Energy (UEC) Following an Impressive Quarter

Y

France's OVHcloud plans frontier AI models to become Europe's second LLM player

Y

Target brings back iconic partnership after 17-year shutdown

Y

Mark Zuckerberg admits mistakes in leaked memo after Meta layoffs

Y

Kiyosaki issues blunt reality check to Americans: ‘Savers of cash will be big losers.’ 5 real assets he likes instead

Y

Elon Musk’s SpaceX has been on a wild ride post-IPO. Should you try to get on?

Y

Saudis seek EU approval for $55 billion EA deal, decision by July 22

Y

Huawei CFO's admissions can be used against company at criminal trial, US judge rules

Y

Bed Bath & Beyond to acquire Fathom Holdings for $53M in "Everything Home" push

Y

DTCC to Tokenize Russell 1000 Stocks and Treasuries in July Pilot With BlackRock and Goldman Sachs

Y

Dan Ives Has a $400 Price Target on Apple. After WWDC, Here's Whether He's Right.

Y

How new payments tech is fueling Huntington's merger conversions

Y

Mondelez CEO appointed AB InBev chairman

Y

GE Vernova Supplier Breaks Out As Data Centers Lift Construction Sector

Y

After SpaceX, Amazon Could Be The Next Best Space Stock

Y

Why Is ASML Stock Up Again Today?

Y

Full-Time Prop Trader Shares What They Wish They Knew Before Becoming Consistently Profitable. 'You're Not Thinking Clearly – You're Reacting'

Y

AMD, Arm, Intel Get Price-Target Hikes On 'CPU Renaissance'

Y

The IPO Onslaught Is Forcing Bankers to Pick Teams

Y

CME Group CFO to take long-time CEO’s seat

Y